Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

NRF2 activation with Protandim attenuates salt-induced vascular dysfunction and microvascular rarefaction.

Priestley JRC, Fink KE, McCord JM, Lombard JH.

Microcirculation. 2019 Oct;26(7):e12575. doi: 10.1111/micc.12575. Epub 2019 Jun 19.

PMID:
31132190
2.

Influence of Nrf2 activators on subcellular skeletal muscle protein and DNA synthesis rates after 6 weeks of milk protein feeding in older adults.

Konopka AR, Laurin JL, Musci RV, Wolff CA, Reid JJ, Biela LM, Zhang Q, Peelor FF 3rd, Melby CL, Hamilton KL, Miller BF.

Geroscience. 2017 Apr;39(2):175-186. doi: 10.1007/s11357-017-9968-8. Epub 2017 Mar 10.

3.

Protandim Protects Oligodendrocytes against an Oxidative Insult.

Lim JL, van der Pol SM, Baron W, McCord JM, de Vries HE, van Horssen J.

Antioxidants (Basel). 2016 Sep 7;5(3). pii: E30. doi: 10.3390/antiox5030030.

4.

Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis.

Abusarah J, Benabdoune H, Shi Q, Lussier B, Martel-Pelletier J, Malo M, Fernandes JC, de Souza FP, Fahmi H, Benderdour M.

J Cell Biochem. 2017 May;118(5):1003-1013. doi: 10.1002/jcb.25659. Epub 2017 Jan 5.

PMID:
27463229
5.

Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.

Strong R, Miller RA, Antebi A, Astle CM, Bogue M, Denzel MS, Fernandez E, Flurkey K, Hamilton KL, Lamming DW, Javors MA, de Magalhães JP, Martinez PA, McCord JM, Miller BF, Müller M, Nelson JF, Ndukum J, Rainger GE, Richardson A, Sabatini DM, Salmon AB, Simpkins JW, Steegenga WT, Nadon NL, Harrison DE.

Aging Cell. 2016 Oct;15(5):872-84. doi: 10.1111/acel.12496. Epub 2016 Jun 16.

6.

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

Lisk C, McCord J, Bose S, Sullivan T, Loomis Z, Nozik-Grayck E, Schroeder T, Hamilton K, Irwin DC.

Free Radic Biol Med. 2013 Oct;63:264-73. doi: 10.1016/j.freeradbiomed.2013.05.024. Epub 2013 May 27.

7.

The role of Nrf2 in the attenuation of cardiovascular disease.

Reuland DJ, McCord JM, Hamilton KL.

Exerc Sport Sci Rev. 2013 Jul;41(3):162-8. doi: 10.1097/JES.0b013e3182948a1e. Review.

PMID:
23558695
8.

Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress.

Reuland DJ, Khademi S, Castle CJ, Irwin DC, McCord JM, Miller BF, Hamilton KL.

Free Radic Biol Med. 2013 Mar;56:102-11. doi: 10.1016/j.freeradbiomed.2012.11.016. Epub 2012 Nov 30.

PMID:
23201694
9.

Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?

Voelkel NF, Bogaard HJ, Al Husseini A, Farkas L, Gomez-Arroyo J, Natarajan R.

Antioxid Redox Signal. 2013 May 10;18(14):1810-7. doi: 10.1089/ars.2012.4828. Epub 2012 Sep 28. Review.

PMID:
22870869
10.

Phytochemical activation of Nrf2 protects human coronary artery endothelial cells against an oxidative challenge.

Donovan EL, McCord JM, Reuland DJ, Miller BF, Hamilton KL.

Oxid Med Cell Longev. 2012;2012:132931. doi: 10.1155/2012/132931. Epub 2012 May 22.

11.

Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation.

Hybertson BM, Gao B, Bose SK, McCord JM.

Mol Aspects Med. 2011 Aug;32(4-6):234-46. doi: 10.1016/j.mam.2011.10.006. Epub 2011 Oct 15. Review.

12.

Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway.

Joddar B, Reen RK, Firstenberg MS, Varadharaj S, McCord JM, Zweier JL, Gooch KJ.

Free Radic Biol Med. 2011 Mar 15;50(6):700-9. doi: 10.1016/j.freeradbiomed.2010.12.008. Epub 2010 Dec 15.

PMID:
21167278
13.

Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim.

Velmurugan K, Alam J, McCord JM, Pugazhenthi S.

Free Radic Biol Med. 2009 Feb 1;46(3):430-40. doi: 10.1016/j.freeradbiomed.2008.10.050. Epub 2008 Nov 17.

PMID:
19056485

Supplemental Content

Loading ...
Support Center